Position in PBM
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$0
+$0 QoQ
Shares Held
500,000
0.0% QoQ
Ownership
13.1%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Calamos Advisors LLC holds $119,501,074 across 23 Biotechnology names. PBM ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
75,388 | $37,447,481 | |
| 2 | RPRX |
Royalty Pharma plc
|
573,521 | $32,157,322 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,578 | $7,219,346 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
22,435 | $7,091,478 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
121,755 | $6,916,901 | |
| 6 | CYTK |
Cytokinetics Inc
|
51,443 | $4,382,428 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
19,711 | $3,691,476 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
14,699 | $3,597,874 |
No Holdings History
No holdings records found for this institution in PBM.